Newsletter SignupSearch

Second Annual Brain Trust: Pathways to InnoVAtion

The U.S. Department of Veterans Affairs (VA) is hosting Brain Trust: Pathways to InnoVAtion, a two-day event focused on brain health. This second annual public-private partnership meeting will take place on May 17-19, 2017 in Boston, MA.

Second Annual Brain Trust: Pathways to InnoVAtion

The U.S. Department of Veterans Affairs (VA) is hosting Brain Trust: Pathways to InnoVAtion, a two-day event focused on brain health. This second annual public-private partnership meeting will take place on May 17-19, 2017 in Boston, MA.

VA Brain TrustBrain Trust: Pathways to InnoVAtion will help foster debate and facilitate national, partnership-based solutions in the general area of traumatic brain injury (TBI) and head trauma. This annual event is designed to promote forward-thinking dialogue and innovative collaboration among private industry, national/professional sports organizations, the Federal government, innovators, scientists, athletes, clinicians, care-givers, and Veterans. Day 1 will consist of plenary and break-out sessions focused on identifying critical brain health solutions to better serve Veterans and their families. Day 2 will have Innovation Demo Day,” where industry and academic innovators can demonstrate current innovations in the areas of TBI and head trauma.

Cohen Veterans Bioscience and Cohen Veterans Network will be presenting at this year’s VA Brain Trust event we hope to see our partners there!

Share this article:

More from CVB

American Brain Coalition Selects Cohen Veterans Bioscience Executive as New Board Member

New Artificial-Intelligence-based Tools for Monitoring Parkinson’s Disease using Wearable Devices

Peter Hoehn, Accomplished Pharmaceutical Executive, Joins Cohen Veterans Bioscience (CVB) in Newly Created Executive Leadership Role

About Cohen Veterans Bioscience (CVB)

Cohen Veterans Bioscience is a non-profit 501(c)(3) biomedical research and technology organization dedicated to advancing brain health by fast-tracking precision diagnostics and tailored therapeutics.